Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis

The purpose of this study is to investigate whether the Y402H polymorphism (rs1061170, a T-to-C transition at amino acid position 402) in the complement factor H (CFH) gene have a pharmacogenetics effect on the anti-vascular endothelial growth factor (VEGF) treatment for neovascular age-related macu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guohai, Tzekov, Radouil, Li, Wensheng, Jiang, Fangzheng, Mao, Sihong, Tong, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585967/
https://www.ncbi.nlm.nih.gov/pubmed/26411831
http://dx.doi.org/10.1038/srep14517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585967/
https://www.ncbi.nlm.nih.gov/pubmed/26411831
http://dx.doi.org/10.1038/srep14517

Ejemplares similares